FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...